The use of LMWH in pregnancies at risk: new evidence or perception?
Walker
I D
ID
Department of Haematology, Glasgow Royal Infirmary, Glasgow, UK.
Kujovich
J L
JL
Greer
I A
IA
Rey
E
E
David
M
M
Salmon
J E
JE
Hunt
B J
BJ
Zotz
R B
RB
Gerhardt
A
A
Scharf
R E
RE
Middeldorf
S
S
Martinelli
I
I
Cetin
I
I
Grandone
E
E
D000026:Abortion, Habitual / Q000188:drug therapy / Q000517:prevention & control; D000022:Abortion, Spontaneous / Q000517:prevention & control; D000925:Anticoagulants / Q000627:therapeutic use; D002985:Clinical Protocols / Q000592:standards; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy / Q000517:prevention & control; D011256:Pregnancy Outcome; D018566:Pregnancy, High-Risk; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight